1. Home
  2. VTAK vs NAOV Comparison

VTAK vs NAOV Comparison

Compare VTAK & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$2.05

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Logo NanoVibronix Inc.

NAOV

NanoVibronix Inc.

HOLD

Current Price

$3.94

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTAK
NAOV
Founded
2002
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
4.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
VTAK
NAOV
Price
$2.05
$3.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
28.8K
26.8K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$730,000.00
$2,685,000.00
Revenue This Year
$822.86
N/A
Revenue Next Year
$168.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
82.96
N/A
52 Week Low
$1.49
$3.55
52 Week High
$15.68
$162.50

Technical Indicators

Market Signals
Indicator
VTAK
NAOV
Relative Strength Index (RSI) 47.34 39.03
Support Level $1.50 $3.83
Resistance Level $2.19 $5.36
Average True Range (ATR) 0.18 0.45
MACD 0.03 0.01
Stochastic Oscillator 61.45 19.34

Price Performance

Historical Comparison
VTAK
NAOV

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About NAOV NanoVibronix Inc.

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.

Share on Social Networks: